T-Cell Lymphoma Forum
Call for Abstracts

The planning committee welcomes the submission of abstracts for the 17th Annual T-Cell Lymphoma Forum. Submitted abstracts will be considered for acceptance as a poster presentation, and will also be considered for an oral presentation during the scientific program.

Selected posters will be displayed throughout the conference in person and online, and will be highlighted during the “Sushi and Science Poster Session.”

Abstract Submission Requirements

  • Abstracts must be submitted on or before October 31, 2025.

  • Abstracts must be submitted in English.

  • Abstracts must be 250 words or less. Tables and images may not be included with the abstract submission but will be permitted in the poster presentation.

  • Abstracts should provide an accurate, succinct, and informative representation of the content you plan to present and be relevant to the science, research, treatment and care of patients with T-Cell Lymphoma.

  • Abstracts must avoid commercial bias and be free of promotion and advertising.

  • Presenting authors of accepted abstracts are required to register and attend the Forum. Register at TCellLymphForum.com. 

Desired Topics

  • New Drugs for the Treatment of T-Cell Lymphoma

  • Insights Into the Pathology and Pathogenesis of T-Cell Malignancies

  • New Epidemiologic Data

  • Results From National/International Registries

  • New Insights Into Biological Targeting of T-Cell Malignancies (New Prospects)

  • Therapy and Results From Ongoing Clinical Trials

  • Deep Dive Into CTCL

For questions, contact Monica McCommon at monica.mccommon@uvahealth.org.